Le Zinc (Zn) est un métal important pour de nombreux processus physiologiques, notamment dans le métabolisme osseux. Cette étude a pour objectif d'évaluer l'implication possible de transporteurs de zinc (ZIP) dans l'influx de Cd dans la cellule. Le cadmium (Cd), métal cancérigène pour l'homme est suspecté d'emprunter certains ZIP, en particulier ZIP4 responsable de l'absorption intestinale du Zn, par mimétisme ionique. Des études montrent que ZIP8 participe à l'accumulation de Cd dans certains tissus. Parallèlement à la lignée cellulaire intestinale Caco-2, indifférenciés (J7) et différenciés (J21), la lignée ostéoblastique MG63 a été choisie. L'expression d'acide ribonucléique messager (ARNm) de ZIP 1, 4, 8 et hZTL1 a été déterminée par transcription inverse et polymérisation en chaîne (RT-PCR). Dans les cellules Caco-2, l'expression de ZIP8 et de hZTL1 est stable, celle de ZIP4 augmente avec la différenciation tandis que l'expression de ZIP1 diminue avec celle-ci. Les cellules MG63 expriment les ZIP et hZTL1 à des niveaux comparables. La détection par immunofluorescence de ZIP4 à la membrane des cellules Caco-2 confirme les résultats obtenus par RT-PCR. Le transport de 109Cd (0.5 µM) a été mesuré dans plusieurs conditions expérimentales afin de tester une éventuelle compétition entre le Zn, le Cd et le manganèse (Mn). Dans les cellules Caco-2 (J7, J21), les pourcentages d'inhibition (70% du transport saturable) par le Zn et le Mn sont comparables. Dans les cellules MG63, l'accumulation de 109Cd est plus fortement inhibée par le Zn que par le Mn. L'ajout de HCO3- augmente l'inhibition par le Zn et le Mn. Ces résultats suggèrent que ZIP8 et ZIP4 sont impliqués en partie dans l'accumulation de Cd. ______________________________________________________________________________ MOTS-CLÉS DE L’AUTEUR : cellules Caco-2, cellules MG63, zinc, ZIP4, ZIP8, cadmium

The easily utilized energy sources, glycerol, glucose and sucrose were used in broiler starter diets to improve growth performance. Trials investigated the effects of inclusion of easily utilized energy sources (EUES) on broiler duodenum and ileum histological developments. The effects of EUES on CHICKS delayed access to feed were investigated. In trial one, newly hatched chicks were randomly assigned to immediate (IA) or 36 hours delayed access to feed and water (DA) and fed 4 or 8% EUES during first 14 days post hatch. In trial two, males and female chicks were randomly assigned to IA or 48 hours DA, and fed 8% glycerol or glucose diets for a 14 days period. In both trials growth performance, duodenum and ileum developments were affected by dietary treatments. In conclusion, glycerol can be added into broiler starter diets up to 8%.

Cyclosporine forms the cornerstone of therapy to prevent rejection after organ transplantation. However, the clinical use of the drug is compromised by a narrow therapeutic window and a wide inter- and intra-individual variation in metabolism. Cyclosporine is metabolised by the CYP3A4 isoenzymes in both the liver and intestine, while it has been reported that the metabolism of the drug can be inhibited by certain furocoumarin derivatives in grapefruit juice. Methoxsalen (8-methoxypsoralen) is a furocoumarin and a potent inhibitor of the cytochrome P450 system in both the liver and intestine. The study was conducted to investigate the possibility whether methoxsalen may inhibit the metabolism of cyclosporine and thereby increase the bioavailability of the drug. The interaction is of clinical relevance since both drugs are used in the treatment of psoriases. The study, conducted in 12 healthy male volunteers, was a three-way comparative bioavailability study with a wash out period of one week between treatments. The patients received 40 mg methoxsalen, 200 mg cyclosporine or a combination of the two on three separate occasions. Blood samples of 10 ml were collected by venupuncture at the following times: 0, 0.5, 1, 1.5, 2, 2.5, 3.4, 5,6, 8, 12 and 24 hours after drug administration. Methoxsalen was analysed by a high pressure liquid chromatograph method (HPLC) with UV detection (LOQ = 10 ng/ml), while cyclosporine was analysed using a fluorescence polarisation immunoassay (FPIA) technique. There was a statistical significant difference in AUCo-00 and Cmax ' for cyclosporine when methoxsalen was added to the drug regimen. When the methoxsalen levels were compared with those in the presence of cyclosporine, the levels were lower, although the difference was not statistical significant. We conclude that methoxsalen increase the levels of cyclosporine by inhibiting the P450 system enzymes in the liver and intestine. However, the absorption of methoxsalen is highly variable in the same individual which needs to be considered before this interaction can be regarded as being of any clinical relevance. / Thesis (M.Sc.(Pharmacology))--North-West University, Potchefstroom Campus, 2004.

Glucagon-like peptide-2 (GLP-2) augments intestinal adaptation in animal models of short bowel syndrome (SBS) and in adult patients with SBS. However, GLP-2 has not been used as a therapy for pediatric SBS. In this thesis, it is hypothesized that exogenous GLP-2 therapy will improve outcomes of intestinal adaptation in proximal intestinal resection (JI) and distal intestinal resection (JC) neonatal piglet models of SBS. Improvements in morphological parameters (increased small intestinal length) and histological parameters (increased jejunal villus length or jejunal crypt depth) of intestinal adaptation in JI and JC neonatal piglets treated with GLP-2 were observed. However, improved clinical outcomes (fewer days of diarrhea, fewer days on parenteral nutrition, more days on enteral nutrition alone) were only observed in GLP-2 treated JC animals. Since the JC anatomical subtype (no remnant ileum) represents the majority of clinical cases of neonatal SBS, these results support a potential role for GLP-2 therapy in pediatric SBS.

The small intestinal mucosal apical hydrolases are essential to the terminal digestion of enteral nutrients such as carbohydrates, proteins, fats and phosphates, and non-immune defense. Weaning results in the complete replacement of fetal enterocytes with mature adult-type enterocytes and is typified by mucosal atrophy, crypt hyperplasia and compromised digestive and defensive functions. Given these severe physiological changes, we hypothesize that the major apical small intestinal hydrolases will be differentially expressed, allowing for reprogramming and adaptation, in the early-weaned piglet. Therefore, the objectives of this study were to examine changes in the digestive capacity, the catalytic kinetics, and abundances of protein and mRNA of the small intestinal hydrolases, including alkaline phosphatase (IAP), lactase phlorizin hydrolase (LPH), sucrase-isomaltase (SI), maltase-glucoamylase (MGA) and aminopeptidase N (APN), in the early-weaned pigs in comparison with suckling pigs. A total of 20 Yorkshire piglets, 10 suckling (SU) and 10 early-weaned (WN) with an average initial body weight of about 3 kg at the age of 10 d, were used in this study. Weanling piglets were fed a corn and soybean meal-based diet for 12 d. Proximal jejunal samples from both groups were collected. Hydrolase kinetic experiments were conducted using the substrates of lactose (0-75 mM), sucrose (0-75 mM), maltose (0-75 mM), amylose (0-100 mM), p-nitrophenyl phosphate (0-10 mM), and L-alanine-p-nitroanilide hydrochloride (0-16 mM). Abundances of the target gene hydrolase protein and mRNA were analyzed by Western blotting and quantitative real time reverse transcription- polymerase chain reaction (RT-PCR), respectively, using ß-actin as a control. Results from this study demonstrate that early weaning down-regulated (P < 0.05) the digestive capacity and expression of LPH while simultaneously increasing (P < 0.05) the digestive capacity and expression of SI and MGA. Furthermore, weaning decreased (P < 0.05) the digestive capacity and expression of APN and IAP by 35 and 50%, respectively. Thus, the early-weaning process differentially affected the expression of the apical membrane-bound hydrolases of the small intestine. The down-regulation of IAP highlights the reduced microbial detoxifying capacity of the newly weaned piglet and provides some insight into the cascade of immune related events that occur during the post-weaning transition period. The reduced expression of LPH and the simultaneous up-regulation of SI, maltase, and MGA indicate the unique nature of the small intestinal reprogramming that occurs during weaning. These results imply that the early weaning events help the small intestine adapt to the transition to starch digestion. Meanwhile, the down-regulation of the APN expression may be partially responsible for the reduced efficiency of whole body protein utilization, and the pervasive localized immune responses observed in the small intestine of early-weaned piglets. / Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Program, and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)-the University of Guelph Partnership Research Program.

Inflammatory bowel disease causes structural and functional alterations in the enteric nervous system (ENS). Since the onset of intestinal inflammation involves the activation of resident immune cells as well as rapid influx of infiltrating cells, we proposed that changes in the ENS are a result of the release of toxic inflammatory factors. We hypothesized that early damage to the ENS in inflammation is caused by harmful levels of nitric oxide (NO) generated by the enzyme inducible nitric oxide synthase (iNOS) found in immune cells. This was assessed in the 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-model of colitis in rats. Large increases in infiltrating granulocytes, particularly neutrophils and blood-derived monocytes were found in the muscularis layers adjacent to the ENS. A rapid increase in iNOS immunoreactivity in the muscularis regions during early stages of inflammation (6 – 24 hr) was observed. Whether high NO levels generated by chemical donors could be toxic to neurons was tested in a co-culture model of myenteric neurons, smooth muscle and glia enzymatically isolated from neonatal rats. Exposure of co-cultures to NO for 48 hr resulted in significant, concentration dependent decrease in neuron survival. We then developed a model that permitted the direct study of immune cell interactions with myenteric neurons. Myenteric neurons were co-cultured with activated peritoneal immune cells that expressed iNOS and generated high NO levels (49 + 6.2µM) for 48 hr. This caused significant neuronal death, reducing neuron number by 19 + 5%, and disruption of axons. Pre-treatment of immune cells with a selective iNOS-inhibitor, L-NIL resulted in neuron numbers that were not significantly different from control (96 + 2%) suggesting that NO played a central role in mediating the damaging effects of immune cells. Lastly, when direct contact between immune cells and neurons was prevented in the previous experiment through use of trans-wells, unanticipated neurotrophic effects were observed. Increased axon outgrowth (282 + 57%) was detected in addition to loss of the neurotoxic effects in spite of similar experimental conditions. We concluded that proximity and contact plays an important role in determining the nature of immune cell mediated alterations in enteric neurons. / Thesis (Master, Physiology) -- Queen's University, 2009-11-30 10:09:38.384

No description available.

No description available.

No description available.

Endotoxins or lipopolysaccharides (LPS), highly toxic component of the outer membrane of gram-negative bacteria, are normally present in the mammalian gut lumen.In this thesis, I investigated, in laboratory animals, whether these gut-derived endotoxins play a role in pathophysiology resulting from intestinal dysfunctions caused by intestinal ischaemia and heat-stress.In primates, reperfusion of the splanchnic region after a temporary ischaemia was followed by a rapid increase in LPS concentration, first in the hepatic portal plasma and, ten minutes later, in the systemic arterial plasma. Rises in plasma LPS concentrations during or following the temporary intestinal ischaemia was prevented by prophylactic administrations of corticosteroids, anti-LPS IgG antibodies and oral, non-absorpable, antibiotics agents which appear to stabilize cellular membranes, aid the reticuloendothelial system in removal of LPS from the circulation and destroy the intestinal aerobic gramnegative bacteria respectively. In addition, administration of therapeutic anti-LPS antibodies also rapidly reduced the plasma LPS concentrations to baseline during an endotoxaemia. In a control heat-stress model, elevations in plasma LPS concentration commenced at rectal temperatures greater than 41,SoC. Like the intestinal ischaemia model, this occurred first in the hepatic portal plasma, and 10-15 minutes later, in the systemic arterial plasma. Peak plasma LPS levels of about 0,3 ng/ml, measured in heat-stressed primates, have proved in previous studies, to be toxic. A rapid decline in mean arterial pressure was followed by increases in plasma LPS concentrations and heart rates. Reductions in splanchnic blood flow and consequent local ischaemia coupled with thermal injury to the intestinal wall and the liver, may have permitted rises in plasma LPS concentration. Furthermore, as in the ischaemia model, prophylactic administrations of corticosteroids, anti-LPS IgG antibodies, and oral, nonabsorbable antibiotics prevented a rise in plasma LPS concentration. Of importance, prophylaxis with intravenous corticosteroids and 'anti-LPS IgG antibodies increased the survival rates significantly in heat stroke in primates. In addition, monkeys having high titres of "natural" antiLPS IgG antibodies had lower plasma LPS concentrations and survived the induced-heat stroke. It is suggested that other pathophysiologic conditions which compromise the integrity of the gut wall would also lead to the development of an endotoxaemia, and that gutderived endotoxins contribute to the athogenesis of heat stroke and treatments with corticosteroids and anti-LPS IgG antibodies may prove beneficial in other endotoxinrelated disorders. / Thesis (Ph.D.)-University of Natal, Durban, 1988.